GENEVA, July 21 -- NATIONAL CANCER CENTER (323 Ilsan-ro,Ilsandong-gu, Goyang-si,Gyeonggi-do 10408), 국립암센터 (경기도고양시 일산동구일산로323) filed a patent application (PCT/KR2025/000528) for "CLDN18.2-EXPRESSING GASTRIC CANCER CELL LINE FOR EVALUATING EFFICACY AND SAFETY OF CLDN18.2 TARGET DRUGS, AND ANIMAL MODEL COMPRISING SAME" on Jan 09, 2025. With publication no. WO/2025/150936, the details related to the patent application was published on Jul 17, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WI...